Total Payments
$3,387
2024 Payments
$1,666
Companies
15
Transactions
96
Medicare Patients
1,576
Medicare Billing
$192,730
Payment Breakdown by Category
Food & Beverage$3,123 (92.2%)
Education$263.98 (7.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,123 | 93 | 92.2% |
| Education | $263.98 | 3 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $730.90 | 27 | $0 (2024) |
| Gilead Sciences, Inc. | $566.54 | 9 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $382.92 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $375.75 | 10 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $272.59 | 10 | $0 (2024) |
| GENZYME CORPORATION | $233.47 | 6 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $205.32 | 2 | $0 (2021) |
| Madrigal Pharmaceuticals | $181.93 | 4 | $0 (2024) |
| Novo Nordisk Inc | $120.44 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $117.85 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,666 | 57 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($369.45) |
| 2023 | $619.57 | 19 | ABBVIE INC. ($200.43) |
| 2022 | $193.36 | 7 | ABBVIE INC. ($165.41) |
| 2021 | $302.45 | 5 | AbbVie Inc. ($118.05) |
| 2020 | $35.09 | 2 | AbbVie Inc. ($21.62) |
| 2019 | $21.75 | 1 | Gilead Sciences, Inc. ($21.75) |
| 2018 | $331.41 | 3 | Gilead Sciences, Inc. ($331.41) |
| 2017 | $217.39 | 2 | Janssen Scientific Affairs, LLC ($127.40) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: LIVER DISEASE | ||||||
| 12/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: LIVER DISEASE | ||||||
| 11/08/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $131.33 | General |
| Category: LIVER DISEASE | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Immunology | ||||||
| 10/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $111.96 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Gastroenterology | ||||||
| 08/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.27 | General |
| 08/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Gastroenterology | ||||||
| 07/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $111.76 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/30/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 07/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.64 | General |
| 07/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Immunology | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 312 | 312 | $294,360 | $35,435 |
| 2022 | 18 | 410 | 440 | $248,538 | $48,284 |
| 2021 | 18 | 704 | 761 | $419,337 | $91,025 |
| 2020 | 7 | 150 | 167 | $70,151 | $17,987 |
Total Patients
1,576
Total Services
1,680
Medicare Billing
$192,730
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $65,025 | $11,380 | 17.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 53 | $44,877 | $6,743 | 15.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 22 | 22 | $44,457 | $4,497 | 10.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 40 | 40 | $46,196 | $3,051 | 6.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $15,440 | $2,907 | 18.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $10,248 | $2,083 | 20.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $21,018 | $1,977 | 9.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $32,201 | $1,379 | 4.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 13 | $5,345 | $1,275 | 23.9% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 34 | 34 | $9,553 | $142.57 | 1.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 52 | 52 | $54,296 | $10,601 | 19.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 35 | $11,900 | $4,830 | 40.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 54 | $14,789 | $4,553 | 30.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 63 | 65 | $44,327 | $4,215 | 9.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 23 | $15,086 | $4,027 | 26.7% |
| 99236 | Hospital observation or inpatient care admitted and discharged on the same day for high severity problem, typically 55 minutes | Facility | 2022 | 11 | 16 | $11,000 | $2,979 | 27.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 31 | 31 | $25,820 | $2,406 | 9.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 20 | 21 | $15,821 | $2,327 | 14.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 12 | 12 | $11,532 | $2,275 | 19.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 11 | 11 | $10,227 | $2,171 | 21.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $7,401 | $2,077 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 24 | $6,072 | $1,833 | 30.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $4,920 | $1,757 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $6,630 | $1,032 | 15.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 13 | $2,425 | $652.37 | 26.9% |
About Dr. Patrick Mccabe, MD
Dr. Patrick Mccabe, MD is a Gastroenterology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2014. The National Provider Identifier (NPI) number assigned to this provider is 1659798650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Mccabe, MD has received a total of $3,387 in payments from pharmaceutical and medical device companies, with $1,666 received in 2024. These payments were reported across 96 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($3,123).
As a Medicare-enrolled provider, Mccabe has provided services to 1,576 Medicare beneficiaries, totaling 1,680 services with total Medicare billing of $192,730. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Sacramento, CA
- Active Since 03/27/2014
- Last Updated 11/20/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1659798650
Products in Payments
- STELARA (Biological) $491.08
- XIFAXAN (Drug) $369.45
- DUPIXENT (Biological) $351.32
- SKYRIZI (Biological) $284.94
- ENTYVIO (Biological) $272.59
- RINVOQ (Biological) $208.51
- RESMETIROM (Drug) $181.93
- MAVYRET (Drug) $121.45
- Wegovy (Drug) $120.44
- Epclusa (Drug) $106.48
- Vemlidy (Drug) $102.44
- REMICADE (Biological) $89.99
- IBSRELA (Drug) $85.97
- CREON (Drug) $44.12
- DIFICID (Drug) $42.27
- LINZESS (Drug) $40.15
- OCALIVA (Drug) $38.77
- HUMIRA (Biological) $21.28
- XELJANZ (Drug) $13.65
- PLENVU (Drug) $13.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Sacramento
Dr. Joseph Leung, M.d, M.D
Gastroenterology — Payments: $382,939
Gastroenterology $382,939
Christopher Bowlus, M.d, M.D
Gastroenterology — Payments: $174,596
Gastroenterology $174,596
Dr. Antonio Mendoza Ladd, M.d, M.D
Gastroenterology — Payments: $84,349
Gastroenterology $84,349
Dr. Kuldeep Tagore, M.d, M.D
Gastroenterology — Payments: $53,535
Gastroenterology $53,535
Abdul Khaleq, Md, MD
Gastroenterology — Payments: $48,069
Gastroenterology $48,069
Dr. Valentina Medici, M.d, M.D
Gastroenterology — Payments: $30,237
Gastroenterology $30,237